Semaglutide
Semaglutide | 10mg & 20mg
For Research Use Only — Not for Human Consumption
Semaglutide is a synthetic peptide analogue characterized for its interaction with the glucagon-like peptide-1 (GLP-1) receptor. GLP-1 receptor signaling is studied in laboratory research involving metabolic signaling, glucose-dependent cellular responses, energy homeostasis, and related biological pathways. Semaglutide incorporates structural modifications designed to increase stability compared with native GLP-1.
Product Specifications
Product Name: Semaglutide
Available Sizes: 10mg / 20mg
Form: Lyophilized Powder
Packaging: Sealed Research Vial
Research Classification: GLP-1 Receptor Agonist
Intended Use: Laboratory Research Only
Available Variants
10mg Vial: Contains a labeled quantity of 10mg of lyophilized semaglutide research peptide.
20mg Vial: Contains a labeled quantity of 20mg of lyophilized semaglutide research peptide.
Research Applications
Semaglutide is studied in controlled research models examining:
-
GLP-1 receptor signaling
-
Metabolic signaling pathways
-
Glucose-dependent cellular responses
-
Energy homeostasis
-
Incretin receptor activity
Research Use Disclaimer
For laboratory research use only. Not intended for human or animal consumption, clinical use, diagnostic use, or therapeutic applications.
-
Estimated Delivery:Nov 21 - Nov 25
TECHNICAL SPECIFICATIONS +